Hi all
pretty new to all this. I have pumped some into Deltex - looks like a strong product with good growth. Could be a steady gainer.
Does anyone else have this, and anyone have some research on it? Someone with more experience than me!
thanks in advance.
Grajul

Yet another almost none news RNS.

I wonder how much rent increase there has been, as anyone knows, a threat to not renew a lease with reason of redevelopment puts the owner in a powerful place when it comes to negotiating.

Anyone have any idea how much per annum the previous agreement was for.

Must admit that whenever I see a RNS for Deltex I no longer get exited as I always expect a sort of none news,

Watching Deltex is becoming a bit like waiting for sex, when you are younger the excitement builds then ends up in a climax, after many years of expectations it can often end in deflation well before the final act.

What is needed is a bit of Viagra, not for myself of course but for Deltex by way of a RNS that really means something.

Agreed, the SP tells it all - I'm not really interested in the "Lease" issue . . . the bigger picture is they need more Products. Relying on one "Idea" is very risky, since ANOther Co might include your feature, just to boost customer perception . . . since these probes are pretty-much 1-trip they are dependent on the availability of their machine to drive it. All very clever as I read the Co outpourings . . . but it's SALES that matter and if the Chairman's petrol allowance went hand-in-hand ( with sp), he'd be turning up on a bike.

Agree, it means absolutely nothing what the pro or negative Deltexers (now there's a new word) think, the product ain't selling in sufficient quantities to keep this company going much longer.

Received reply to an e-mail sent in response to the following,

http://www.iii.co.uk/stockmarketwire/224192/lidco-reports-further-clinical-support-lidcorapid?context=LSE:LID

I think you have a valid point that there is a weakness in our financial PR!! We will look to address this.

As we are always happy to clarify anything for any holder, it would be good for everyone if they were to contact us rather than speculate. NB I am referring to the business/scientific matters rather than the more emotional parts: we had a difficult year last year and a bad close in December, the share price is terrible and I fully understand that some of our long term supporters are upset. This does not however mean the Company isn’t wildly undervalued.

Re the Lidco announcement, I am as surprised that Lidco’s NOMAD allowed them to make it as I am that a peer review journal (even a low grade one like this) published the study.

- this was a small & bizarre study on healthy 30 year olds not an elderly or sick group having major surgery
- the idea that the Lidcorapid is sensitive enough to detect withdrawal of 125ml of blood is preposterous. Rather than go into technical details, suffice to say that it needed 6 times as much (750mls) being re-infused before it detected any change! Actually the CardioQ got sensible results and overall, as you would expect, did better than any other technology, however the statistics are a mess so very hard to tell
- the paper also noted that blood pressure fell with the first removal of blood before stabilising: as Lidco has been shown time & again to track pressure rather than flow, it looks like it just got lucky - it has been found out too often to not think this was a freak
- re discomfort: yes a Doppler probe is a bit uncomfortable, but I would put one down any day in preference to an invasive arterial line despite the gag reaction, Secondly the paper actually reported that the discomfort was worst when an USCOM device was used - hardly surprising as this needs to be pushed quite firmly into the base of the throat to get a signal therefore pushing against the probe in the oesophagus

Personally, I think Lidco feeling the need to put this out & have a dig at Deltex shows just how worried they are at our technological superiority.
They got away with it in the UK for a while when the NHS decided to encourage the use of any IOFM device rather than the only one to be NICE recommended (ours) - but the NHS totally screwed up the implementation and they, like us, are back to relying on clinical effectiveness. Despite multiple efforts, Lidco have yet to get one single trial of its kit intra-operatively (as opposed to post-operatively in a more stable ICU environment where it has one good result & one poor) to deliver a statistically significant positive outcome - we have got plenty and some crackers on the way.

Have a look at the meta-analysis at http://www.deltexmedical.com/education/meta-analysis/ - the bottom four are all Lidco studies and all those ever published attempting a Stroke-Volume Optimisation strategy during surgery using their box. If you have a spare few minutes you might want to have a look at Lidco’s website and see if you can find any of these referenced or discussed. It is increasingly obvious that this particular emperor is wearing no clothes - perhaps this is why the CEO has decided to give up?

Hope this helps: happy to explain anything in more depth.

Kind regards

Ewan

Ewan Phillips
Chief Executive - CEO
Deltex Medical Group plc

That's certainly put Lidco in it's place, the CEO is also sounding upbeat.
2517

Agree, he also sounds more frustrated than we are!

RNS,

Results out on 11th March and a presentation for analysts will take place on the same day. Lets just hope there is news re contracts either on the day or before it, if not I can't see any presentation doing much good.

RNS.

As expected, so not going to comment, except to say I am becoming numb to the continuing lack of progress.

Funny that, 'cause I don't see these Results too bad - the hoped-for NHS Order is surely positive...but what really matters is how the Market see it and with an 8% fall today I guess it's not good.
This Co need to develop another product and PDQ. This would give them more-up-front costs but in time should provide additional sales. Frankly it could be something "Simples" -that any good salesman might find talking to the Customer over a pint ( er, of Tea). Face-to-face contact is the only way to discover these "Needs" and in the Operating Theatre; one suspects there must be many times the Staff say " Why don't we have "....? " = some product to make things better.
- But Deltex just doesn't see their Business that way.
Today sp is 4.25 pence.

Edited and re posted

Hi Hangon,

I will comment sufficient to say that I like most investors expected Deltex to have profits in the several millions by now, not the single figure million sales (not profits) that they have achieved to date.

Profits are still none existent and yet we had been promised such a couple of years ago.

My village corner shop makes more profit than Deltex does.

We all know the saying, if it ain't broke don't fix it, but the present strategy is broke so what do Deltex have to loose by changing it, possibly as I have suggested many times by entering a full partnership with another company, one with the clout that Deltex lack but obviously need.

I still feel Deltex will make it, but not without yet another cash call, and how many more after that.

Nice to see 3 directors buying, they must know that something good is round the corner and buying now before they get into a none dealing time zone.

http://www.moneyam.com/action/news/showArticle?id=4996154

The trade of 1,000,000 marked sell (at 6.47p) was a delayed trade from 11:46:03 when the bid was 6.00 and the offer was 6.25, so this trade had to be a buy.

Someone paid over full price for these 1 million shares!

RNS re further trial results.

Todays RNS,

The market obviously think it's just another trickle of good news that indicates that things are still moving far too slowly.

It appears that whenever we get a RNS these days it is just another reason for the sp to fall mainly because investors are becoming more and more disillusioned with a lack of big sp raising news.

It has been said many times that it's contracts that we wait for and little else will be accepted.

To prove my point I purposely did not post earlier as I wanted to see just how much interest today's RNS would generate.

No doubt many will disagree with me but unless they can put a good slant on this, I will continue to see Deltex as a company that will continue to struggle.

I see this like PRM another Bio-Co that doesn't want to sell its Tech ( OR is that they can't??? ). It's a difficult position to be in when the Execs know how good their product is but no-one else is prepared to change their work-ethic......merely nodding "That's a good idea" is rather like saving your chip-oil to run your car - when your present car uses Petrol.

[[ If these two ( and many others, the List is long!) were Retail Shops they would be operating in a town with huge unemployment issues, seasonal Zero-hour employers and their shop would be something like a rusty lock-up, behind the main drag ( so foot access only), right next to the Car-Park Lifts that broke three years ago and opposite the Toilets that were closed ten years ago due to glue-sniffing. However, they did get a 25yr lease - but even that looks expensive by today's prices.
++It's not looking too good. - and any Ann. that the execs have chosen the colour of paint for the shop roller-shutters doesn't really excite anyone. Even if that was a council-based contract to paint the shutters next-door as well it would not even get in the local papers -unless a small-ad for the excess paint... er, Grey anyone? Unused 5x 10lit. (I joke!)..]].


Still, one should be grateful that there are Execs there, earning themselves money, pensions, perks, etc. waiting for the rush.
- Just hope I don't die of boredom beforehand.

Hi Hangon,

Most of your comments will greatly upset many investors who still strongly believe in Deltex, but there is no getting away from facts.

I said a while ago that my local shop is making more profit than Deltex and the only thing that matters is 'Is the product selling' and the answer is 'No, not insufficient quantities to save the company'.

Things might and probably will change for the better, but will this change come soon enough.
The way things look it's a long shot.

Sorry Greekman, no negs intended, . . . . rather a jolt to Execs ( if any care to read, etc.), Since the sp is telling us there is little interest in this co. despite the Co believing it has a really good product....that was why I became interested, at nearly 20p!
One wonders if selling to the NHS is a cost-effective use of a Salesman's time, if the probe-sales are somewhat low ( so-called Cutbacks)* . . . Co. needs to have more machines out there ( Everywhere I hear you say!), and maybe reduce the probe-cost after they have bought 100, or similar incentive.
I'm not even sure I like the Co Name - it doesn't have a Brave New World ring about it - Closer to drain cleaner ( Oh wash my mouth - but not in Dx).

Clearly you have doubts and that's reflected in their (share) Trades.

PS * It matters not that NHS can save money-per-op. by better outcomes ( ie use probes), if the NHS Buying department is not allowed to. So, I suspect the Salesman needs to be talking to the Divisional NHS bods that set Policy,
-only IF the probes really are beneficial, as we are led to believe . . . . indeed I wonder if there has been a full assessment of the finances/Ops to prove the Case . . . . but as a very minor investor no-one asks me.
Greekman - this may yet shine, but not IMHO with the present NHS set-up. I just hope the Execs hold-on, - so I may see a tiny profit for the Trust I held, er, Hold.....Their US-training school news is good and bt a few at low prices.

EDIT (22April2015)-Energeticbuyer - that Co News is similar to one other recently - good to know the Co is selling probes, but that's what we've been expecting - indeed without this there is no point in them making probes/instruments......Let's hope this activity is likely to continue.

Morning Hangon,

No prob, I do find that it is hard not to be negative re Deltex.

Deltex today announced it has established its ninth US trainer account at a prestigious teaching hospital in Boston. This will provide training to prospective users of the Group’s advanced ODM equipment and software.

This agreement also includes the procurement of at least 500 probes for inclusion in the hospital’s 2015/16 budget year starting in October 2015. In the interim the hospital is purchasing probes on an ad hoc basis and has placed three orders of 50 probes each time over the last four months.

New research note at http://tinyurl.com/nr9n37z